With 22.97 million shares changed hands, the volume of the stock remained heavier than its average volume of 10.33 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $3.3600 whereas the lowest price it dropped to was $3.0000. The 52-week range on GERN shows that it touched its highest point at $3.73 and its lowest point at $1.64 during that stretch. It currently has a 1-year price target of $5.08. Beta for the stock currently stands at 0.52.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of GERN was up-trending over the past week, with a rise of 41.11%, but this was up by 51.19% over a month. Three-month performance surged to 51.91% while six-month performance rose 38.04%. The stock gained 21.18% in the past year, while it has gained 50.47% so far this year. A look at the trailing 12-month EPS for GERN yields -0.32 with Next year EPS estimates of -0.11. For the next quarter, that number is -0.10. This implies an EPS growth rate of 1.56% for this year and 65.61% for next year. EPS is expected to grow by 5.00% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -16.08%.
Float and Shares Shorts:
At present, 544.91 million GERN shares are outstanding with a float of 447.58 million shares on hand for trading. On Feb 29, 2024, short shares totaled 44.91 million, which was 8.22% higher than short shares on Jan 31, 2024. In addition to GERN as the firm’s Geron Corporation, GEN serves as its Gen Digital Inc.
Institutional Ownership:
Through their ownership of 73.01% of GERN’s outstanding shares, institutional investors have majority control over the company.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for GERN since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.
Dividends & Yield:
In terms of dividends, GERN has a current ratio of $––, which is $–– over the trailing 12-months, while a dividend of $–– is likely to be paid on average over the next five years. Dividend yield is another indicator that appeals to many investors, and GERN currently yields $0.00. In the past year, GERN’s dividend yield has been $0.00, but when looking at the stock over the past five years, its yield has been $–. Accordingly, GERN has a current buyback yield of $––. This was $–– for the TTM, and it was $–– for the past five years.
